natgillin/translations-raw huggingface dataset:
NovoMix 30 is a biphasic suspension of the insulin analogue, insulin aspart. 
Zdravilo NovoMix 30 je dvofazna suspenzija insulinskega analoga, insulina aspart.
NovoMix 30 is presented as a suspension for injection. 
Zdravilo NovoMix 30 je na voljo v obliki suspenzije za injiciranje.
Do not use the pen if the resuspended insulin does not look uniformly white, cloudy and aqueous. 
Vložka ne uporabite, če suspenzija insulina ni enakomerno bela, motna in vodna.
Always keep the cartridge in the outer carton when you are not using it, in order to protect it from light. 
Kadar vložka ne uporabljate, ga vedno shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
Pack sizes of 1, 5 and 10 pre-filled pens. 
Pakiranja z 1, 5 in 10 napolnjenimi injekcijskimi peresniki.
NovoMix 30 is a mixture consisting of 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine. 
Zdravilo NovoMix 30 je mešanica, ki vsebuje 30 % topnega insulina aspart in 70 % insulina aspart, kristaliziranega s protaminom.
Picture A 
Uporabno do
Instruction on how to use NovoMix 30 suspension for injection in FlexPen. 
Navodila za uporabo zdravila NovoMix 30 suspenzija za injiciranje v injekcijskem peresniku FlexPen
► Needles and NovoMix 70 Penfill must not be shared. 
► Igel in zdravila NovoMix 70 Penfill si ne delite z drugimi.
► There are no restrictions on treatment with NovoMix 70 during breast-feeding. 
► Pri uporabi zdravila NovoMix 70 med dojenjem ni omejitev.
NovoMix 70 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 70 is essentially ‘sodium-free'. 
Zdravilo NovoMix 70 vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
NovoMix 70 is for subcutaneous administration only. 
Zdravilo NovoMix 70 je namenjeno zgolj subkutani uporabi.
50% soluble insulin aspart and 50% insulin aspart crystallised with protamine 
50 % topnega insulina aspart in 50 % insulina aspart, kristaliziranega s protaminom
Before you use NovoMix 70 FlexPen, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 70 FlexPen uporabili, ga vzamite iz hladilnika.
NovoMix 30 is presented as a suspension for injection in a pre-filled pen. 
Zdravilo NovoMix 30 je na voljo v obliki suspenzije za injiciranje v napolnjenem injekcijskem peresniku.
NovoMix 30 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 30 is essentially ‘sodium-free'. 
Zdravilo NovoMix 30 vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
NovoMix 70 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 70/30. 
Kako ravnati z injekcijskim peresnikom NovoMix 70 FlexPen Injekcijski peresnik NovoMix 70 FlexPen je napolnjen, barvno kodiran injekcijski peresnik za enkratno uporabo, ki vsebuje mešanico hitrodelujočega in srednjedolgodelujočega insulina aspart v razmerju 70/30.
► Needles and NovoMix 30 FlexPen must not be shared. 
► Igel in zdravila NovoMix 30 FlexPen si ne delite z drugimi.
NovoMix 30 is a biphasic suspension of 30% soluble insulin aspart (rapid-acting human insulin analogue) and 70% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue). 
Zdravilo NovoMix 30 je dvofazna suspenzija, s 30 % topnega insulina aspart (hitrodelujočega analoga humanega insulina) in 70 % s protaminom kristaliziranega insulina aspart (srednjedolgodelujočega analoga humanega insulina).
► If you suspect hypoglycaemia (low blood sugar) is starting, see a) Summary of serious and very common side effects in section 4. 
Vsebina pakiranja in dodatne informacije), ► če sumite, da se začenja hipoglikemija (nizek krvni sladkor) (glejte poglavje 4, podpoglavje a)
► After each injection, be sure to remove and discard the needle and store NovoMix 30 without the needle attached. 
► Po vsakem injiciranju morate iglo odstraniti in zavreči, zdravilo NovoMix 30 pa shraniti brez nameščene igle.
NovoMix 30 FlexPen 100 units/ml 
NovoMix 30 FlexPen 100 enot/ml suspenzija za injiciranje
Before you use NovoMix 70 Penfill, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 70 Penfill uporabili, ga vzamite iz hladilnika.
The crystalline phase (70%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalno fazo (70 %) sestavlja s protaminom kristalizirani insulin aspart, ki ima podoben profil delovanja kot humani insulin NPH.
• If the second and third characters are H7 or T6, the manufacturer is Novo Nordisk Production 
• Če sta drugi in tretji znak S6, P5, K7, R7, VG, FG ali ZF, je izdelovalec Novo Nordisk A/S,
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections 
FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi glicerol fenol metakrezol cinkov klorid natrijev hidrogenfosfat dihidrat natrijev klorid protaminijev sulfat klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH) voda za injekcije
NovoMix 70 FlexPen 100 units/ml 
NovoMix 70 FlexPen 100 enot/ml suspenzija za injiciranje
The crystalline phase (50%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalno fazo (50 %) sestavlja s protaminom kristalizirani insulin aspart, ki ima podoben profil delovanja kot humani insulin NPH.
NovoMix 70 FlexPen is only suitable for subcutaneous injections. 
Zdravilo NovoMix 70 FlexPen je primerno samo za podkožno injiciranje.
NovoMix 30 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 30/70. 
Kako ravnati z injekcijskim peresnikom NovoMix 30 FlexPen Injekcijski peresnik NovoMix 30 FlexPen je napolnjen, barvno kodiran injekcijski peresnik za enkratno uporabo, ki vsebuje mešanico hitrodelujočega in srednjedolgodelujočega insulina aspart v razmerju 30/70.
See Resuspension of NovoMix 30 in section 3. 
Glejte poglavje 3, podpoglavje Resuspendiranje zdravila NovoMix 30.
See Resuspension of NovoMix 50 in section 3. 
Glejte poglavje 3, podpoglavje Resuspendiranje zdravila NovoMix 50.
The crystalline phase (30%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalno fazo (30 %) sestavlja s protaminom kristalizirani insulin aspart, ki ima podoben profil delovanja kot humani insulin NPH.
Before you use NovoMix 50 FlexPen, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 50 FlexPen uporabili, ga vzamite iz hladilnika.
NovoMix 30 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
Zdravilo NovoMix 30 se z injekcijo aplicira subkutano v stegno ali trebušno steno.
Keep the cap on FlexPen in order to protect it from light. 
Injekcijski peresnik FlexPen, naj bo pokrit s pokrovčkom za zagotovitev zaščite pred svetlobo.
Before you use NovoMix 30 FlexPen, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 30 FlexPen uporabili, ga vzamite iz hladilnika.
NovoMix 70 Penfill 100 units/ml 
NovoMix 70 Penfill 100 enot/ml suspenzija za injiciranje
Before you use NovoMix 30 Penfill, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 30 Penfill uporabili, ga vzamite iz hladilnika.
Suspension for injection 1 x 3 ml cartridge 5 x 3 ml cartridges 10 x 3 ml cartridges 
suspenzija za injiciranje 1 x 3 ml vložek
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (CARTRIDGE. 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (NAPOLNJEN INJEKCIJSKI PERESNIK FlexPen)
NovoMix 50 FlexPen is only suitable for subcutaneous injections. 
Zdravilo NovoMix 50 FlexPen je primerno samo za podkožno injiciranje.
See Resuspension of NovoMix 70 in section 3. 
Glejte poglavje 3, podpoglavje Resuspendiranje zdravila NovoMix 70.
Before you use NovoMix 50 Penfill, remove it from the refrigerator. 
Preden boste zdravilo NovoMix 50 Penfill uporabili, ga vzamite iz hladilnika.
► There are no restrictions on treatment with NovoMix 30 during breast-feeding. 
► Pri uporabi zdravila NovoMix 30 med dojenjem ni omejitev.
Patients transferred to NovoMix 30 from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products. 
utegnejo potrebovati večje število dnevnih injekcij ali drugačen odmerek kot med uporabo svojih običajnih insulinskih zdravil.
Always keep the pen cap on your FlexPen when you are not using it, in order to protect it from light. 
Kadar injekcijskega peresnika FlexPen ne uporabljate, naj bo vedno pokrit s pokrovčkom za zagotovitev zaščite pred svetlobo.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription. 
A. IZDELOVALCI BIOLOŠKE UČINKOVINE IN IZDELOVALCI, ODGOVORNI ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM D. POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA
NovoMix 70 Penfill and NovoMix 70 FlexPen: 
NovoMix 70 Penfill in NovoMix 70 FlexPen: Novo Nordisk A/S
NovoMix 30 FlexPen is only suitable for subcutaneous injections. 
Zdravilo NovoMix 30 FlexPen je primerno samo za podkožno injiciranje.
1 pre-filled pen contains 3 ml equivalent to 300 units. 
En napolnjen injekcijski peresnik vsebuje 3 ml, kar ustreza 300 enotam.
70% soluble insulin aspart and 30% insulin aspart crystallised with protamine 
70 % topnega insulina aspart in 30 % insulina aspart, kristaliziranega s protaminom
NAME OF THE MEDICINAL PRODUCT NovoMix 50 FlexPen 100 units/ml 
IME ZDRAVILA IN POT UPORABE NovoMix 50 FlexPen 100 enot/ml suspenzija za injiciranje
NAME OF THE MEDICINAL PRODUCT NovoMix 70 Penfill 100 units/ml suspension for injection in cartridge NovoMix 70 FlexPen 100 units/ml suspension for injection in pre-filled pen 
IME ZDRAVILA NovoMix 70 Penfill 100 enot/ml suspenzija za injiciranje v vložku
► There are no restrictions on treatment with NovoMix 50 during breast-feeding. 
► Pri uporabi zdravila NovoMix 50 med dojenjem ni omejitev.
► Needles and NovoMix 50 Penfill must not be shared. 
► Igel in zdravila NovoMix 50 Penfill si ne delite z drugimi.
No clinical studies with NovoMix 70 have been carried out in children and adolescents under the age of 18 years. 
Uporaba pri otrocih in mladostnikih Pri otrocih in mladostnikih do 18. leta starosti klinične študije z zdravilom NovoMix 70 niso bile izvedene.
► NovoMix 70 Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► Vložki NovoMix 70 Penfill so namenjeni za uporabo v sistemih za dajanje insulina Novo Nordisk in z iglami NovoFine ali NovoTwist.
NovoMix 30 Penfill 100 units/ml 
NovoMix 30 Penfill 100 enot/ml suspenzija za injiciranje
NovoMix 50 Penfill and NovoMix 50 FlexPen: 
NovoMix 50 Penfill in NovoMix 50 FlexPen: Novo Nordisk A/S
The remaining 70% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 70 % je v kristalni obliki, kot insulin aspart, kristaliziran s protaminom, ki ima podaljšan potek absorpcije, podoben humanemu insulinu NPH.
50% soluble insulin aspart and 50% insulin aspart crystallised with protamine SC use 
50 % topnega insulina aspart in 50 % insulina aspart, kristaliziranega s protaminom za subkutano uporabo
The remaining 50% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 50 % je v kristalni obliki, kot insulin aspart, kristaliziran s protaminom, ki ima podaljšan potek absorpcije, podoben humanemu insulinu NPH.
NovoMix 50 FlexPen 100 units/ml suspension for injection in a pre-filled pen 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine 
NovoMix 50 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku 50 % topnega insulina aspart in 50 % insulina aspart, kristaliziranega s protaminom
NovoMix 70 FlexPen is only suitable for injecting under the skin. 
Zdravilo NovoMix 70 FlexPen je primerno samo za injiciranje pod kožo.
Only use resuspension if uniformly white, cloudy and aqueous For use by one person only 
Suspenzijo uporabite le, če je enakomerno bela, motna in vodna.
NAME OF THE MEDICINAL PRODUCT NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen 
IME ZDRAVILA NovoMix 30 Penfill 100 enot/ml suspenzija za injiciranje v vložku
MARKETING AUTHORISATION NUMBERS EU/1/00/142/011 1 cartridge of 3 ml EU/1/00/142/012 5 cartridges of 3 ml EU/1/00/142/013 10 cartridges of 3 ml 
EU/1/00/142/011 1 vložek s 3 ml EU/1/00/142/012 5 vložkov s 3 ml EU/1/00/142/013 10 vložkov s 3 ml
NAME OF THE MEDICINAL PRODUCT NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen 
IME ZDRAVILA NovoMix 50 Penfill 100 enot/ml suspenzija za injiciranje v vložku
► Needles and NovoMix 30 Penfill must not be shared. 
► Igel in zdravila NovoMix 30 Penfill si ne delite z drugimi.
► NovoMix 70 FlexPen is only suitable for injecting under the skin. 
► Zdravilo NovoMix 70 FlexPen je primerno samo za injiciranje pod kožo.
NovoMix 70 Penfill is only suitable for subcutaneous injections from a reusable pen. 
Zdravilo NovoMix 70 Penfill je primerno samo za podkožno injiciranje z injekcijskim peresnikom za večkratno uporabo.
Do not use the insulin, if it does not look uniformly white, cloudy and aqueous after resuspension. 
Če suspenzija insulina ni enakomerno bela, motna in vodna, je ne uporabite.
► NovoMix 50 Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► Vložki NovoMix 50 Penfill so namenjeni za uporabo v sistemih za dajanje insulina Novo Nordisk in z iglami NovoFine ali NovoTwist.
Pointer 
Injiciranje
NovoMix 50 Penfill 100 units/ml suspension for injection in a cartridge 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine 
NovoMix 50 Penfill 100 enot/ml suspenzija za injiciranje v vložku 50 % topnega insulina aspart in 50 % s protaminom kristaliziranega insulina aspart
NovoMix 50 is for subcutaneous administration only. 
Zdravilo NovoMix 50 je namenjeno zgolj subkutani uporabi.
The remaining 30% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 30 % je v kristalni obliki, kot insulin aspart, kristaliziran s protaminom, ki ima podaljšan potek absorpcije, podoben humanemu insulinu NPH.
MARKETING AUTHORISATION NUMBERS EU/1/00/142/017 1 cartridge of 3 ml EU/1/00/142/018 5 cartridges of 3 ml EU/1/00/142/019 10 cartridges of 3 ml 
EU/1/00/142/017 1 vložek s 3 ml EU/1/00/142/018 5 vložkov s 3 ml EU/1/00/142/019 10 vložkov s 3 ml
NovoMix 70 Penfill is only suitable for injecting under the skin using a reusable pen. 
Zdravilo NovoMix 70 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
Ask your doctor, nurse or pharmacist for advice before taking any medicine while pregnant or breastfeeding. 
Če ste noseči ali če dojite, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom, preden vzamete katero koli zdravilo.
What NovoMix 30 contains 
Kaj vsebuje zdravilo NovoMix 30
► NovoMix 50 FlexPen is only suitable for injecting under the skin. 
► Zdravilo NovoMix 50 FlexPen je primerno samo za injiciranje pod kožo.
NovoMix 50 FlexPen is only suitable for injecting under the skin. 
Zdravilo NovoMix 50 FlexPen je primerno samo za injiciranje pod kožo.
No clinical studies with NovoMix 50 have been carried out in children and adolescents under the age of 18 years. 
Uporaba pri otrocih in mladostnikih Pri otrocih in mladostnikih do 18. leta starosti klinične študije z zdravilom NovoMix 50 niso bile izvedene.
MARKETING AUTHORISATION NUMBERS EU/1/00/142/020 1 pen of 3 ml EU/1/00/142/021 5 pens of 3 ml EU/1/00/142/022 10 pens of 3 ml 
ŠTEVILKE DOVOLJENJ ZA PROMET EU/1/00/142/020 1 injekcijski peresnik s 3 ml EU/1/00/142/021 5 injekcijskih peresnikov s 3 ml
► NovoMix 70 Penfill is only suitable for injecting under the skin using a reusable pen. 
► Zdravilo NovoMix 70 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
NovoMix 50 Penfill is only suitable for subcutaneous injections from a reusable pen. 
Zdravilo NovoMix 50 Penfill je primerno samo za podkožno injiciranje z injekcijskim peresnikom za večkratno uporabo.
NovoMix 30 Penfill is only suitable for subcutaneous injections from a reusable pen. 
Zdravilo NovoMix 30 Penfill je primerno samo za podkožno injiciranje z injekcijskim peresnikom za večkratno uporabo.
NovoMix 30 FlexPen is only suitable for injecting under the skin. 
Zdravilo NovoMix 30 FlexPen je primerno samo za injiciranje pod kožo.
Always remove the needle after each injection and store your FlexPen without the needle attached. 
Po vsakem injiciranju morate iglo odstraniti in zavreči, injekcijski peresnik FlexPen pa shraniti brez nameščene igle.
EU/1/00/142/023 1 pen of 3 ml EU/1/00/142/009 5 pens of 3 ml EU/1/00/142/010 10 pens of 3 ml EU/1/00/142/024 1 pen of 3 ml and 7 NovoFine needles EU/1/00/142/025 1 pen of 3 ml and 7 NovoTwist needles 
EU/1/00/142/010 10 injekcijskih peresnikov s 3 ml EU/1/00/142/024 1 injekcijski peresnik s 3 ml in 7 igel NovoFine
During use or when carried as a spare: NovoMix 70 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Med uporabo in ko zdravilo uporabljate kot rezervo: zdravila NovoMix 70 FlexPen, ki ga uporabljate ali ga imate pri sebi za rezervo, ne shranjujte v hladilniku.
Before opening: NovoMix 70 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Pred odprtjem: zdravilo NovoMix 70 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C - 8 °C in ne blizu hladilnega elementa.
► NovoMix 30 FlexPen is only suitable for injecting under the skin. 
► Zdravilo NovoMix 30 FlexPen je primerno samo za injiciranje pod kožo.
STATEMENT OF ACTIVE SUBSTANCE 
za subkutano uporabo
During use or when carried as a spare: NovoMix 70 Penfill that is being used or carried as a spare should not be kept in the refrigerator. 
Med uporabo in ko zdravilo uporabljate kot rezervo: zdravila NovoMix 70 Penfill, ki ga uporabljate ali ga imate pri sebi za rezervo, ne shranjujte v hladilniku.
1 ml of the suspension contains 100 units soluble insulin aspart*/protamine-crystallised insulin aspart* in the ratio 50/50 (equivalent to 3.5 mg). 
1 ml suspenzije vsebuje 100 enot topnega insulina aspart*/s protaminom kristaliziranega insulina aspart* v razmerju 50/50 (kar ustreza 3,5 mg).
NovoMix 30 Penfill is only suitable for injecting under the skin using a reusable pen. 
Zdravilo NovoMix 30 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
What NovoMix 70 contains 
Kaj vsebuje zdravilo NovoMix 70
30% soluble insulin aspart and 70% insulin aspart crystallised with protamine SC use 
30 % topnega insulina aspart in 70 % insulina aspart, kristaliziranega s protaminom za subkutano uporabo
Check with your doctor, nurse or pharmacist if you are not sure. 
Če niste prepričani, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom.
NovoMix 70 FlexPen 100 units/ml suspension for injection in a pre-filled pen 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine 
NovoMix 70 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku 70 % topnega insulina aspart in 30 % insulina aspart, kristaliziranega s protaminom
NovoMix 50 Penfill is only suitable for injecting under the skin using a reusable pen. 
Zdravilo NovoMix 50 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
Before opening: NovoMix 70 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Pred odprtjem: zdravilo NovoMix 70 Penfill, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C - 8 °C in ne blizu hladilnega elementa.
NovoMix 30 Penfill 100 units/ml suspension for injection in a cartridge 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine 
NovoMix 30 Penfill 100 enot/ml suspenzija za injiciranje v vložku 30 % topnega insulina aspart in 70 % insulina aspart, kristaliziranega s protaminom
70% soluble insulin aspart and 30% insulin aspart crystallised with protamine SC use 
70 % topnega insulina aspart in 30 % insulina aspart, kristaliziranega s protaminom za subkutano uporabo
Before opening: NovoMix 50 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Pred odprtjem: zdravilo NovoMix 50 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C - 8 °C in ne blizu hladilnega elementa.
1 ml suspension contains 100 units soluble insulin aspart/protamine-crystallised insulin aspart in the ratio 50/50 (equivalent to 3.5 mg). 
1 ml suspenzije vsebuje 100 enot topnega insulina aspart/s protaminom kristaliziranega insulina aspart v razmerju 50/50 (kar ustreza 3,5 mg),
During use or when carried as a spare: NovoMix 50 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Med uporabo in ko zdravilo uporabljate kot rezervo: zdravila NovoMix 50 FlexPen, ki ga uporabljate ali ga imate pri sebi za rezervo, ne shranjujte v hladilniku.
If any of these apply, do not use NovoMix 70. 
Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 70 Ne uporabljajte zdravila NovoMix 70:
MARKETING AUTHORISATION NUMBERS EU/1/00/142/004 5 cartridges of 3 ml EU/1/00/142/005 10 cartridges of 3 ml 
ŠTEVILKE DOVOLJENJ ZA PROMET EU/1/00/142/014 1 injekcijski peresnik s 3 ml EU/1/00/142/015 5 injekcijskih peresnikov s 3 ml
► NovoMix 50 Penfill is only suitable for injecting under the skin using a reusable pen. 
► Zdravilo NovoMix 50 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
► NovoMix 30 Penfill is only suitable for injecting under the skin using a reusable pen. 
► Zdravilo NovoMix 30 Penfill je primerno samo za injiciranje pod kožo z injekcijskim peresnikom za večkratno uporabo.
• If the moving procedure alone is not enough to give a uniformly white, cloudy and aqueous liquid, repeat the rolling and moving procedures described above until the liquid appears uniformly white, cloudy and aqueous. 
• Če s tem postopkom ne dobite enakomerno bele, motne in vodne tekočine, ga ponavljajte,
Before opening: NovoMix 30 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Pred odprtjem: zdravilo NovoMix 30 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C - 8 °C in ne blizu hladilnega elementa.
NovoMix 30 FlexPen 100 units/ml suspension for injection in a pre-filled pen 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine 
NovoMix 30 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku 30 % topnega insulina aspart in 70 % insulina aspart, kristaliziranega s protaminom
NovoMix 50 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
Zdravilo NovoMix 50 Penfill je namenjeno za uporabo v sistemih za dajanje insulina Novo Nordisk in iglami NovoFine ali NovoTwist.
During use or when carried as a spare: NovoMix 30 Penfill that is being used or carried as a spare should not be kept in the refrigerator. 
Med uporabo in ko zdravilo uporabljate kot rezervo: zdravila NovoMix 30 Penfill, ki ga uporabljate ali ga imate pri sebi za rezervo, ne shranjujte v hladilniku.
During use or when carried as a spare: NovoMix 30 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Med uporabo in ko zdravilo uporabljate kot rezervo: zdravila NovoMix 30 FlexPen, ki ga uporabljate ali ga imate pri sebi za rezervo, ne shranjujte v hladilniku.